GEN-MKT-18-7897-A
Oct 2, 2018 | Biopharma, Blogs, Life Science Research | 0 comments
There are a lot of conferences vying for your attention every year. The Global CESI-MS Symposium on October 10-11 in the Netherlands is one you can’t afford to miss. It is the place to hear about the latest advancements made through the adoption of CESI-MS technology.
Have you signed up yet? If not, keep reading to find out more.
What is CESI-MS?The integration of Capillary Electrophoresis (CE) with Electrospray Ionization (ESI) into a single dynamic process within the same device brings new capabilities to biopharmaceutical, proteomics, metabolomics, and industrial researchers. When paired with a mass spectrometer, CESI-MS delivers a revolutionary approach to discovering previously undetectable characteristics from the minutest precious sample.
The Global Symposium provides a platform for scientists in biopharma, proteomics, metabolomics research, and applied markets to share knowledge and advance their work with CESI-MS technologies. Organized by SCIEX, over the last three years, the event has become synonymous with innovation, check out last year’s presentations.
What’s on the Agenda?Find out about the unique features of CESI-MS and how it is helping to push research and applied applications to the very limits. You will hear how CESI-MS is making inroads in applications where researchers are working with very limited amounts of samples, such as charged and polar analytes in metabolite profiling, and intact proteins in proteomics and biopharma. Professor Govert Somsen and Professor Manfred Wuhrer will host the two-day program which is packed with presentations and Q&A sessions featuring 15 industry innovators – see the full agenda here.
What’s New In CESI-MS in 2018?At the Symposium you will hear about scientific breakthroughs in a range of applications, including:
These are just four examples of the many exciting pioneering stories we will hear at the 2018 Global CESI-MS Symposium.
Why Should I Attend?Over two days of presentations and Q&A, you will discover strategies, methods, and breakthroughs achieved with CESI-MS. This is a rare opportunity to hear and discuss these great cases, first-hand.
So, what are you waiting for? Come and join us at the 2018 Global CESI-MS Symposium on October 10-11, 2018 at Leiden University Medical Center (LUMC) in The Netherlands.
Spaces are filling fast; we hope to see you there.
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
At SCIEX, innovation doesn’t stop at instruments; it extends to how you interact with your LC-MS/MS or CE systems every day. That’s why we’re excited to introduce the SCIEX Now spring 2026 improvements: a set of meaningful enhancements shaped directly by your feedback.
Posted by
You must be logged in to post a comment.
Share this post with your network